During the past decade, Hematology Oncology Associates of Eastern Idaho conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematology Oncology Associates of Eastern Idaho" #1 sponsor was "SWOG Cancer Research Network" with 4 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Oncology Associates of Eastern Idaho" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Oncology Associates of Eastern Idaho" are "Breast Cancer" (3 trials), "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (1 trials), "Adenocarcinoma of the Rectum" (1 trials), "Adult Acute Megakaryoblastic Leukemia" (1 trials) and "Adult Acute Monocytic Leukemia" (1 trials). Many other conditions were trialed in "Hematology Oncology Associates of Eastern Idaho" in a lesser frequency.

Most popular intervention types in "Hematology Oncology Associates of Eastern Idaho" are "Drug" (9 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (2 trials), "radiation therapy" (2 trials), "tamoxifen citrate" (2 trials), "Clinical Observation" (1 trials) and "O6-Benzylguanine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Oncology Associates of Eastern Idaho" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hematology Oncology Associates of Eastern Idaho". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hematology Oncology Associates of Eastern Idaho, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Oncology Associates of Eastern Idaho, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Hematology Oncology Associates of Eastern Idaho has several departments that took part in Clinical trials: "Teton Cancer Institute" - 2 trials